1 |
李旭艳,谢院生,陈香美. 肾小管上皮-间充质转化的研究现状[J/CD]. 中华肾病研究电子杂志,2013,2(2):98-102.
|
2 |
Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease [J]. Cell, 2009, 139(5):871-890.
|
3 |
Larue L, Bellacosa A. Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways [J]. Oncogene, 2005, 24(50):7443-7454.
|
4 |
Guo F, Parker Kerrigan BC, Yang D, et al. Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions [J]. J Hematol Oncol, 2014, 7:19.
|
5 |
Tang H, Massi D, Hemmings BA, et al. AKT-ions with a TWIST between EMT and MET [J]. Oncotarget, 2016, [Epub ahead of print].
|
6 |
Kim HY, Jackson TR, Davidson LA. On the role of mechanics in driving mesenchymal-to-epithelial transitions [J]. Semin Cell Dev Biol, 2016, [Epub ahead of print].
|
7 |
Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis [J]. Cell, 1996, 84(3):345-357.
|
8 |
Fleming TP, McConnell J, Johnson MH, et al. Development of tight junctions de novo in the mouse early embryo: control of assembly of the tight junction-specific protein, ZO-1 [J]. J Cell Biol, 1989, 108(4):1407-1418.
|
9 |
Roberts SJ, Leaf DS, Moore HP, et al. The establishment of polarized membrane traffic in Xenopus laevis embryos [J]. J Cell Biol, 1992, 118(6):1359-1369.
|
10 |
Vainio S, Lin Y. Coordinating early kidney development: lessons from gene targeting [J]. Nat Rev Genet, 2002, 3(7):533-543.
|
11 |
Dressler GR. The cellular basis of kidney development [J]. Annu Rev Cell Dev Biol, 2006, 22:509-529.
|
12 |
Chao Y, Wu Q, Acquafondata M, et al. Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases [J]. Cancer Microenviron, 2012, 5(1):19-28.
|
13 |
Ocana OH, Corcoles R, Fabra A, et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1 [J]. Cancer Cell, 2012, 22(6):709-724.
|
14 |
Stone RC, Pastar I, Ojeh N, et al. Epithelial-mesenchymal transition in tissue repair and fibrosis [J]. Cell Tissue Res, 2016, 365(3):495-506.
|
15 |
Eming SA, Martin P, Tomic-Canic M. Wound repair and regeneration: mechanisms, signaling, and translation [J]. Sci Transl Med, 2014, 6(265):265-266.
|
16 |
Tan B, Pascual A, de Beus A, et al. TGFbeta (transforming growth factor beta) and keratocyte motility in 24 h zebrafish explant cultures [J]. Cell Biol Int, 2011, 35(11):1131-1139.
|
17 |
Esteban MA, Bao X, Zhuang Q, et al. The mesenchymal-to-epithelial transition in somatic cell reprogramming [J]. Curr Opin Genet Dev, 2012, 22(5):423-428.
|
18 |
Pattabiraman DR, Bierie B, Kober KI, et al. Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability [J]. Science, 2016, 351(6277):aad3680.
|
19 |
Zeisberg M, Hanai J, Sugimoto H, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury [J]. Nature Med, 2003, 9(7):964-968.
|
20 |
Xu Y, Wan J, Jiang D, et al. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition in human renal proximal tubular epithelial cells [J]. J Nephrol, 2009, 22(3):403-410.
|
21 |
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors [J]. Cell, 2006, 126(4):663-676.
|
22 |
Wu HJ, Yiu WH, Li RX, et al. Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis [J]. PloS One, 2014, 9(3):e90883.
|
23 |
Ebrahimi B, Eirin A, Li Z, et al. Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis [J]. PloS One, 2013, 8(7):e67474.
|
24 |
Bullock MD, Sayan AE, Packham GK, et al. MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression [J]. Biol Cell, 2012, 104(1):3-12.
|
25 |
Chung AC, Yu X, Lan HY. MicroRNA and nephropathy: emerging concepts [J]. Int J Nephrol Renovasc Dis, 2013, 6:169-179.
|
26 |
Xiong M, Jiang L, Zhou Y, et al. The miR-200 family regulates TGF-beta1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression [J]. Am J Physiol Renal Physiol, 2012, 302(3):F369-379.
|
27 |
Aoyama T, Yamamoto S, Kanematsu A, et al. Local delivery of matrix metalloproteinase gene prevents the onset of renal sclerosis in streptozotocin-induced diabetic mice [J]. Tissue Eng, 2003, 9(6):1289-1299.
|
28 |
Yoshikawa M, Hishikawa K, Marumo T, et al. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells [J]. J Am Soc Nephrol, 2007, 18(1):58-65.
|
29 |
Kang SW, Lee SM, Kim JY, et al. Therapeutic activity of the histone deacetylase inhibitor SB939 on renal fibrosis [J]. Int Immunopharmacol, 2016, 42:25-31.
|
30 |
Zhu FQ, Chen MJ, Zhu M, et al. Curcumin suppresses epithelial-mesenchymal transition of renal tubular epithelial cells through the inhibition of Akt/mTOR pathway [J]. Biol Pharm Bull, 2016, [Epub ahead of print].
|
31 |
Galichon P, Finianos S, Hertig A. EMT-MET in renal disease: should we curb our enthusiasm? [J]. Cancer Lett, 2013, 341(1):24-29.
|